Viracta Therapeutics Stock (NASDAQ: VIRX) stock price, news, charts, stock research, profile.
Open | $0.51 |
Close | $0.50 |
Volume / Avg. | 41.50K / 90.97K |
Day Range | 0.48 - 0.51 |
52 Wk Range | 0.43 - 1.68 |
Market Cap | $18.97M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 2.34% |
Days to Cover | 8.36 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Viracta Therapeutics (NASDAQ:VIRX) through any online brokerage.
Other companies in Viracta Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Evaxion Biotech (NASDAQ:EVAX), Can Fite Biofarma (AMEX:CANF) and Sensei Biotherapeutics (NASDAQ:SNSE).
There is no analysis for Viracta Therapeutics.
Viracta Therapeutics has a consensus price target of $7.20.
The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $0.483 last updated July 23, 2024 at 4:07 PM EDT.
There are no upcoming dividends for Viracta Therapeutics.
Viracta Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Viracta Therapeutics.
Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.